Possible new target for sickle cell disease and beta thalassemia treatment identified

Дата публикации: 30-09-2026 19:20:21

Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA approves gene therapy for children with sickle cell disease ages 2+	5	7	09-07-2026
2	Sickle cell pain may involve previously unrecognized biological pathways	0	7.35	06-10-2026
3	FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies	0	14.59	12-08-2026
4	Potential new therapeutic targets for preeclampsia discovered	0	8.49	24-07-2026
5	Gene Therapy Cures Soccer-Loving Boy of Beta Thalassemia	0	24.6	22-06-2026
6	Vertex Announces FDA Approval for Expanded Use of Casgevy for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	0	9.35	01-07-2026
7	Black children at risk for severe form of asthma, new research shows	0	6.5	16-10-2026
8	Boosting a key brain protein could help treat Rett syndrome	0	8.25	07-03-2026
9	New screening for virus that causes newborn hearing loss	0	5.24	21-09-2026
10	Создана методика для ускорения разработки новых лекарств от болезней сосудов	0	0	16-10-2025

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.74. Источник: medicalxpress.com.